Clinical & Diagnostic

MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced its ultra-high-throughput genetic sequencer DNBSEQ-T7 received the medical device registration certificate from the Korea Ministry of Food and Drug Safety (MFDS)....

AOI Revolutionizes Cancer Care in Telangana with AI-Powered Ethos Radiotherapy, Becomes Advanced Cancer Centre

Inaugurated by the Minister for Finance, Health, Medical & Family Welfare, Government of Telangana ...

Medtronic Welcomes ESH Guidelines on Renal Denervation for Hypertension Treatment

Medtronic is excited by the updated European Hypertension Society (ESH) guidelines that highlight the role of renal denervation (RDN) as part of the hypertension care pathway. The guidelines were announced at the ESH 32nd Annual Meeting and simultaneously published in the Journal of Hypertension....

Lunit's AI Solution Impacts Radiologists' Lung Cancer Diagnosis

Recent study conducted by Seoul National University Hospital provides strong evidence that high-accuracy AI model improves radiologists' chest X-ray analysis performance...

GMS Announces Partnership With Lumina Imaging And Diagnostics

Group Management Services (GMS), a leading professional employer organization (PEO) headquartered in Richfield, Ohio, is pleased to announce its partnership with Lumina Imaging and Diagnostics. This collaboration revolutionizes the health care landscape for GMS clients and their employees throughout Northeast Ohio....

BD India's Pledge for Safety Initiative Launched with a 'Safety Flame' March from Ruby Hall Clinic

To enhance awareness around the importance of safety protocols, practices, and technologies to deliver optimum Patient and clinical outcomes as well as enable knowledge-sharing of best practices around this key area, BD (Becton, Dickinson, and Company) recently organized the ‘Pledge for Safety' - Clinical Leaders Forum....

APAC Cardiovascular Disease Alliance to tackle heart disease in Asia

Building interdisciplinary, multisectoral partnerships to unite CVD action across borders...

Roche Gets FDA Clearance for Additional Alzheimer's CSF Assays, Enhancing Diagnosis and Treatment Decisions

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Elecsys AD CSF Abeta42 and tTau assays (used as a tTau/Abeta42 ratio) measure two biomarkers of Alzheimer's pathology, beta-amyloid and tau proteins, in adults ages 55 and older being evaluated for the disease....